Publications

//php custom_breadcrumbs() ?>
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
Go to the Link
2023
Systematic identification of gene-altering programmed inversions across the bacterial domain
O. Milman, I. Yelin, R. Kishony
2022
Multistep diversification in spatiotemporal bacterial-phage coevolution
E. Shaer-Tamar, R. Kishony
Antibiotic combinations reduce Staphylococcus aureus clearance
V. Lázár, O. Snitser, D. Barkan, R. Kishony
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections
M. Stracy, O. Snitser, I. Yelin, Y. Amer, M. Parizade, R. Katz, G. Rimler, T. Wolf, E. Herzel, G. Koren, J. Kuint, B. Foxman, G. Chodick, V. Shalev, R. Kishony
Host-parasite coevolution promotes innovation through deformations in fitness landscapes
A. Gupta, L. Zaman, H.M. Strobel, J. Gallie, A.R. Burmeister, B. Kerr, E. Shaer-Tamar, R.Kishony†, J.R. Meyer†
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections
H. Chung, C. Merakou, M. M. Schaefers, K. B. Flett, S. Martini, R. Lu, J. A. Blumenthal, S. S. Webster, A. R. Cross, R. Al Ahmar, E. Halpin, M. Anderson, N. S. Moore, E. C. Snesrud, H. D. Yu, J. B. Goldberg, G. A. O'Toole, P. McGann, J. A. Stam, M. Hinkle, A. J. McAdam, R. Kishony†, G. P. Priebe†
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
M. Levine-Tiefenbrun, I. Yelin, H. Alapi, E. Herzel, J. Kuint, G. Chodick, S. Gazit, T. Patalon†, R. Kishony†
2021
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
M. Levine-Tiefenbrun, I. Yelin, H. Alapi, R. Katz, E. Herzel, J. Kuint, G. Chodick, S. Gazit, T. Patalon†, R. Kishony†
Rapid methicillin resistance diversification in Staphylococcus epidermidis colonizing human neonates
M.S. Datta*, I. Yelin*, O. Hochwald, I. Kassis, L. Borenstein-Levin, A. Kugelman & R. Kishony.
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals
O. Milman*, I. Yelin*, N. Aharony, R. Katz, E. Herzel, A. Ben-Tov, J. Kuint, S. Gazit, G. Chodick, T. Patalon†, R. Kishony†
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
M. Levine-Tiefenbrun*, I. Yelin*, R. Katz, E. Herzel, Z. Golan, L. Schreiber, T. Wolf, V. Nadler, A. Ben-Tov, J. Kuint, S. Gazit, T. Patalon, G. Chodick, R. Kishony
Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities
I. Yelin, R. Katz, E. Herzel, T. Berman-Zilberstein, A. Ben-Tov, J. Kuint, S. Gazit, T. Patalon, G. Chodick, R. Kishony
2020
Antibiotic resistance: turning evolutionary principles into clinical reality
D.I. Andersson, N.Q. Balaban, F. Baquero, P. Courvalin, , P. Glaser, U. Gophna, R. Kishony, S. Molin, T. Tønjum
2019
2018
2017
2016
Evolutionary stability of microbial communities with antibiotic degrading species
E. D. Kelsic, K. Vetsigian*, R. Kishony*
2015
2014
2013
2012
2011
2010
2009
2008
Nongenetic individuality in the host-phage interaction
S. Pearl, C. Gabay, R. Kishony, A. Oppenheim, N. Q. Balaban